Two NIAID grants will support research on impacts of climate change on HIV-related health outcomes

Two grants from the National Institute of Allergies and Infectious Diseases (NIAID), a four-year $3.2 million award and a 12-month $550,000 administrative supplement, will support innovative research to advance the understanding of how climate change and extreme weather influence HIV-related health outcomes around the world.

The future of third-party logistics in an evolving biopharmaceutical world – Pharmaceutical Technology

Despite inflationary pressures and ongoing challenges in the geopolitical landscape, expectations are high regarding the biopharmaceutical industry’s growth prospects. A survey conducted by third-party logistics

December 16, 2024

Lusaris Therapeutics: From Promising Psychedelic Startup to Vanishing Act | Psychedelic Invest

In November 2022, Lusaris Therapeutics made news for its $60 million Series A round. Since then, there has been a curious silence from the company.

September 13, 2023

In-person contact decreases levels of loneliness in older people

In-person contact helps lead to lower levels of loneliness in older people, but other ways of staying in touch, such as phoning, emailing or texting,

August 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.